Synageva
Synageva is a biopharmaceutical firm that focuses on discovery, development and commercialization of therapeutic products for rare diseases.
Business Model:
Revenue: $5.8M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Synageva Information
Synageva was acquired by
Alexion Pharmaceuticals.
The acquisition happend on 2015-05-06.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 33 Hayden Ave
City: Lexington
State: MA
Zip: 02421
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$308M
Raised Total:$70M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Synageva is a biopharmaceutical firm that focuses on discovery, development and commercialization of therapeutic products for rare diseases.
Contact Phone:
+17813579900
Contact Email:
Synageva went public on 11/11/2011 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/11/2011
Ticker Symbol:
GEVA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
